inflammatory conditions

game over pivot new direction
Pharma

InflaRx may find path forward for COVID drug in skin disorder

Positive post hoc analyses could prompt InflaRx to revive development of its COVID med vilobelimab in the rare skin disorder pyoderma gangrenosum.
Fraiser Kansteiner Jan 2, 2026 10:25am
An arrow incrementally going up stairs before pointing straight up Blue background

Regeneron, AZ regulatory plans bolstered by phase 3 wins

Nov 7, 2025 2:00pm
graphic image of different colored hands shaking
Favicon Fierce Biotech

Merck bags $700M from Blackstone, spends $150M to regain asset

Nov 4, 2025 9:15am